INMB

Latest SEC Filings & News for INMB

2 most recent filings and news items mentioning INMB. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/INMB/news?limit=20"

Pull INMB filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Inmune Bio adopts Third Amended and Restated 2021 Stock Incentive Plan

Inmune Bio Inc. has amended and restated its 2021 Stock Incentive Plan to provide equity awards to executives, employees, advisors and board members. The plan modification enables the company to continue incentivizing talent retention and aligning employee interests with long-ter

View filing at SEC.gov →

XPro1595 shows statistically significant effect on white matter MRI biomarker in Alzheimer's trial

INmune Bio reported Phase 2 MINDFuL trial results showing XPro1595 demonstrated significant treatment effects on advanced white matter MRI biomarkers (p=0.0028), with stronger efficacy in inflammation-enriched patients. The findings support the company's precision-medicine approa

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.